Dave Moore

Dave Moore serves as Chief Operating Officer at Toralgen. Toralgen operates in the pharmaceuticals sector with approximately 23.0 employees. The company is headquartered in Indianapolis, Indiana. To date, Toralgen has raised 2000000.0 in total funding, with the most recent round being Seed.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 832 executive contacts are available in Indiana.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Google Cloud Hosting Nginx WordPress.org Mobile Friendly Google Tag Manager Viewpoint Remote AI

pharmaceutical manufacturing biopharmaceuticals drug delivery oral therapeutics nanoparticle technology poly-bile nanoparticles oral bioavailability diabetes treatment autoimmune disorders biologics encapsulation injectable alternatives peptide delivery monoclonal antibodies drug formulation pharma collaboration clinical development oral medication targeted drug delivery natural bile acids minimalistic fabrication microfluidics manufacturing semicontinuous processing drug safety bioactivity retention patient compliance therapeutic efficacy production scalability immunomodulators encapsulated small molecules bile-acid polymers homeostasis control metabolic diseases antigen delivery insulin formulations non-injectable drugs nontoxic carriers biopharmaceutical research regulatory approvals therapeutic interventions cmax improvement lake efficacy streamlined manufacturing strategic partnerships funding rounds market potential innovation in medications revolutionary treatments biotechnology startups pharmaceuticals medical

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Dave Moore in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Toralgen.

Dave Moore's Position in the MessageCEO Database

• •Dave Moore is 1 of 1 verified executive contact we track at Toralgen.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •768 verified executive contacts in Indiana are in the database.
• •8 verified contacts work at pharmaceuticals companies in the 23.0 employee range (same size as Toralgen).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Dave Moore directly?

Dave Moore's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Operating Officer at Toralgen. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Dave Moore work for?

Dave Moore is Chief Operating Officer at Toralgen, a company in the pharmaceuticals sector with 23.0 employees. The company is based in Indianapolis, Indiana.

Can I pitch or sell to Dave Moore?

As Chief Operating Officer at Toralgen, Dave Moore is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Dave Moore directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Dave Moore in?

Dave Moore works in the pharmaceuticals industry as Chief Operating Officer at Toralgen. MessageCEO provides verified contact information for executives across all major industries.

Is Dave Moore's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Dave Moore's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026